Indeed, in Sézary syndrome-derived cell lines, inhibition of PKCβ and GSK3 with the small molecules Enzastaurin and AR-A014418 promote a marked decrease in p38β expression without changing p38α levels [100]. This evidence concerns the gene MAPK11 and Sezary syndrome.